Research Unit on Emerging Infectious and Tropical Diseases, Institut de Recherche pour le Développement, Dakar, Senegal.
Lancet Infect Dis. 2011 Dec;11(12):925-32. doi: 10.1016/S1473-3099(11)70194-3. Epub 2011 Aug 17.
Substantial reductions in malaria have been reported in several African countries after distribution of insecticide-treated bednets and the use of artemisinin-based combination therapies (ACTs). Our aim was to assess the effect of these policies on malaria morbidity, mosquito populations, and asymptomatic infections in a west African rural population.
We did a longitudinal study of inhabitants of Dielmo village, Senegal, between January, 2007, and December, 2010. We monitored the inhabitants for fever during this period and we treated malaria attacks with artesunate plus amodiaquine. In July, 2008, we offered longlasting insecticide (deltamethrin)-treated nets (LLINs) to all villagers. We did monthly night collections of mosquitoes during the whole study period, and we assessed asymptomatic carriage from cross-sectional surveys. Our statistical analyses were by negative binomial regression, logistic regression, and binomial or Fisher exact test.
There were 464 clinical malaria attacks attributable to Plasmodium falciparum during 17,858 person-months of follow-up. The incidence density of malaria attacks averaged 5·45 (95% CI 4·90-6·05) per 100 person-months between January, 2007, and July, 2008, before the distribution of LLINs. Incidence density decreased to 0·41 (0·29-0·55) between August, 2008, and August, 2010, but increased back to 4·57 (3·54-5·82) between September and December, 2010--ie, 27-30 months after the distribution of LLINs. The rebound of malaria attacks were highest in adults and children aged 10 years or older: 45 (63%) of 71 malaria attacks recorded in 2010 compared with 126 (33%) of 384 in 2007 and 2008 (p<0·0001). 37% of Anopheles gambiae mosquitoes were resistant to deltamethrin in 2010, and the prevalence of the Leu1014Phe kdr resistance mutation increased from 8% in 2007 to 48% in 2010 (p=0·0009).
Increasing pyrethroid resistance of A gambiae and increasing susceptibility of older children and adults, probably due to decreasing immunity, caused the rebound and age shift of malaria morbidity. Strategies to address the problem of insecticide resistance and to mitigate its effects must be urgently defined and implemented.
Institut de Recherche pour le Développement and the Pasteur Institute of Dakar.
在非洲的几个国家,由于分发了经杀虫剂处理的蚊帐和使用了青蒿素为基础的联合疗法(ACT),疟疾发病率已大幅下降。我们的目的是评估这些政策对西非农村人口的疟疾发病率、蚊虫种群和无症状感染的影响。
我们对塞内加尔迪埃莫村的居民进行了一项纵向研究,时间为 2007 年 1 月至 2010 年 12 月。在此期间,我们监测居民的发热情况,并使用青蒿琥酯加阿莫地喹治疗疟疾发作。2008 年 7 月,我们向所有村民提供了长效驱虫蚊帐(LLINs)。在整个研究期间,我们每月进行一次夜间蚊虫采集,并通过横断面调查评估无症状携带情况。我们的统计分析采用负二项回归、逻辑回归、二项式或 Fisher 精确检验。
在 17858 人月的随访期间,共发生了 464 例归因于恶性疟原虫的临床疟疾发作。在 2007 年 1 月至 2008 年 7 月 LLINs 分发前,疟疾发作的发病率密度平均为每 100 人月 5.45(95%CI 4.90-6.05)。2008 年 8 月至 2010 年 8 月,发病率密度降至 0.41(0.29-0.55),但 2010 年 9 月至 12 月,即 LLINs 分发后 27-30 个月,又回升至 4.57(3.54-5.82)。疟疾发作的反弹在成年人和 10 岁及以上的儿童中最高:2010 年记录的 71 次疟疾发作中,有 45 次(63%)与 2007 年和 2008 年记录的 384 次发作中的 126 次(33%)相比(p<0·0001)。2010 年,37%的冈比亚按蚊对溴氰菊酯产生抗药性,Leu1014Phe kdr 抗性突变的流行率从 2007 年的 8%上升到 2010 年的 48%(p=0·0009)。
冈比亚按蚊对拟除虫菊酯的抗药性增加,以及大龄儿童和成年人的易感性增加,可能是由于免疫力下降,导致疟疾发病率的反弹和年龄转移。必须紧急确定并实施解决杀虫剂耐药性问题及其影响的策略。
发展研究研究所和达喀尔巴斯德研究所。